1. Home
  2. SYBX vs ELBM Comparison

SYBX vs ELBM Comparison

Compare SYBX & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • ELBM
  • Stock Information
  • Founded
  • SYBX N/A
  • ELBM 2011
  • Country
  • SYBX United States
  • ELBM Canada
  • Employees
  • SYBX N/A
  • ELBM N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • ELBM Industrial Machinery/Components
  • Sector
  • SYBX Health Care
  • ELBM Miscellaneous
  • Exchange
  • SYBX Nasdaq
  • ELBM Nasdaq
  • Market Cap
  • SYBX 16.4M
  • ELBM 19.2M
  • IPO Year
  • SYBX N/A
  • ELBM N/A
  • Fundamental
  • Price
  • SYBX N/A
  • ELBM $2.25
  • Analyst Decision
  • SYBX
  • ELBM Strong Buy
  • Analyst Count
  • SYBX 0
  • ELBM 2
  • Target Price
  • SYBX N/A
  • ELBM $2.20
  • AVG Volume (30 Days)
  • SYBX 17.3K
  • ELBM 3.7M
  • Earning Date
  • SYBX 11-11-2025
  • ELBM 11-14-2025
  • Dividend Yield
  • SYBX N/A
  • ELBM N/A
  • EPS Growth
  • SYBX N/A
  • ELBM N/A
  • EPS
  • SYBX N/A
  • ELBM N/A
  • Revenue
  • SYBX N/A
  • ELBM N/A
  • Revenue This Year
  • SYBX N/A
  • ELBM N/A
  • Revenue Next Year
  • SYBX N/A
  • ELBM N/A
  • P/E Ratio
  • SYBX N/A
  • ELBM N/A
  • Revenue Growth
  • SYBX N/A
  • ELBM N/A
  • 52 Week Low
  • SYBX $0.90
  • ELBM $0.77
  • 52 Week High
  • SYBX $1.96
  • ELBM $2.60
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 57.52
  • ELBM 72.49
  • Support Level
  • SYBX $1.61
  • ELBM $1.15
  • Resistance Level
  • SYBX $1.74
  • ELBM $1.59
  • Average True Range (ATR)
  • SYBX 0.07
  • ELBM 0.16
  • MACD
  • SYBX -0.01
  • ELBM 0.07
  • Stochastic Oscillator
  • SYBX 50.00
  • ELBM 100.00

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

Share on Social Networks: